Your session is about to expire
← Back to Search
Symptom Care at Home for Heart Failure (SCHHF Trial)
N/A
Waitlist Available
Led By Youjeong Kang, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The routine use of diuretics at least daily
Will be discharged home without any post-acute care services
Timeline
Screening 3 weeks
Treatment Varies
Follow Up in the beginning and at the end of the symptom monitoring and sch-hf- before first day monitoring symptoms and at the last day monitoring symptoms (at 30 day)- up to 30 days.
Awards & highlights
SCHHF Trial Summary
This trial is testing if a computer system can help heart failure patients monitor their symptoms and get advice to help manage their condition.
Who is the study for?
This trial is for heart failure patients who can manage at home without extra care, speak English, and have daily phone access. They should be NYHA class II or III, indicating some physical activity limitation due to heart failure. Participants must have a history of hospital readmission and take diuretics regularly.Check my eligibility
What is being tested?
The study tests a telephonic system that tracks symptoms and gives self-management advice to heart failure patients based on their reported conditions. The goal is to see if this technology helps improve patient outcomes by promoting better self-care practices.See study design
What are the potential side effects?
Since the intervention involves using a telephone-based support system rather than medication or invasive procedures, there are no direct side effects associated with its use in the context of this clinical trial.
SCHHF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I take water pills every day.
Select...
I will go home without needing extra care after discharge.
Select...
My heart condition limits my physical activity but I can still perform light tasks.
Select...
I have been diagnosed with heart failure.
SCHHF Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ in the beginning and at the end of the symptom monitoring and sch-hf- before first day monitoring symptoms and at the last day monitoring symptoms (at 30 day)- up to 30 days.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~in the beginning and at the end of the symptom monitoring and sch-hf- before first day monitoring symptoms and at the last day monitoring symptoms (at 30 day)- up to 30 days.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Symptom trajectories
Secondary outcome measures
Self-management behaviors Self-management behaviors Self-management behaviors
SCHHF Trial Design
1Treatment groups
Experimental Treatment
Group I: System with coaching messagesExperimental Treatment1 Intervention
A telephone-computer interface IVR system to report symtopms and to receive coaching messages based on symptom severity.
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,617 Total Patients Enrolled
17 Trials studying Heart Failure
3,207 Patients Enrolled for Heart Failure
Youjeong Kang, PhDPrincipal InvestigatorEmory University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am receiving hospice care at home.I take water pills every day.My heart condition limits my physical activity slightly to markedly.I will go home without needing extra care after discharge.You have been hospitalized before.I do not have end-stage renal failure requiring frequent dialysis.I may have memory or thinking problems based on a simple test.My heart condition limits my physical activity but I can still perform light tasks.I have been diagnosed with heart failure.
Research Study Groups:
This trial has the following groups:- Group 1: System with coaching messages
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment currently available for this experiment?
"Affirmative. According to the data accessible on clinicaltrials.gov, this trial is currently enlisting patients and was initially posted on February 12th 2023. As of March 2nd 2023, 33 participants are required from one location."
Answered by AI
What is the cohort size for this clinical investigation?
"Affirmative. Per the information on clinicaltrials.gov, this study is actively recruiting - it was originally posted on February 12th 2023 and recently updated on March 2nd 2023. 33 patients are hoped to be enrolled at a single medical centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger